rasagiline has been researched along with Lassitude in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stocchi, F | 1 |
| Eyal, E; Smith, KM; Weintraub, D | 1 |
| Fossati, C; Stocchi, F; Torti, M | 1 |
| Fernandez, HH; Gujrati, Y; Hennessy, C; Kluger, BM; Lim, TT; Malaty, IA; Nutter, B; Ojo, OO; Palacio, R; Patel, S; Rodriguez, RL; Swartz, C | 1 |
| Katunina, EA; Sotnikova, NN; Titova, NV | 1 |
| Tarrants, ML; Zagmutt, FJ | 1 |
| Pagonabarraga, J; RodrÃguez-Oroz, MC | 1 |
4 review(s) available for rasagiline and Lassitude
| Article | Year |
|---|---|
Rasagiline for the treatment of Parkinson's disease: an update.
Topics: Antiparkinson Agents; Apoptosis; Clinical Trials as Topic; Cognition Disorders; Drug Therapy, Combination; Fatigue; Humans; Indans; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Parkinson Disease; Quality of Life | 2015 |
[Comorbid states in Parkinson's disease: an effect of MAO-B inhibitors].
Topics: Aged; Antiparkinson Agents; Comorbidity; Depression; Fatigue; Humans; Indans; Monoamine Oxidase Inhibitors; Parkinson Disease | 2016 |
Indirect comparisons of adverse events and dropout rates in early Parkinson's disease trials of pramipexole, ropinirole, and rasagiline.
Topics: Antiparkinson Agents; Benzothiazoles; Cognition Disorders; Cross-Sectional Studies; Databases, Bibliographic; Fatigue; Female; Gastrointestinal Diseases; Humans; Indans; Indoles; Logistic Models; Male; Parkinson Disease; Patient Dropouts; Pramipexole; Sleep Wake Disorders; Treatment Outcome | 2012 |
[Rasagiline in monotherapy in patients with early stages of Parkinson's disease and in combined and adjunct therapy to levodopa with moderate and advanced stages].
Topics: Antiparkinson Agents; Attention; Clinical Trials as Topic; Cognition Disorders; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Executive Function; Fatigue; Headache; Humans; Indans; Levodopa; Monoamine Oxidase Inhibitors; Motor Activity; Multicenter Studies as Topic; Nausea; Neuroprotective Agents; Parkinson Disease; Severity of Illness Index | 2013 |
3 trial(s) available for rasagiline and Lassitude
| Article | Year |
|---|---|
Benefits of treatment with rasagiline for fatigue symptoms in patients with early Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Disease Progression; Double-Blind Method; Fatigue; Female; Humans; Indans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Parkinson Disease; Severity of Illness Index; Treatment Outcome | 2014 |
Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Apathy; Depression; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; Humans; Indans; Male; Middle Aged; Neuroprotective Agents; Parkinson Disease; Psychiatric Status Rating Scales; Severity of Illness Index; Sleep; Treatment Outcome; Wakefulness | 2015 |
Rasagiline for the symptomatic treatment of fatigue in Parkinson's disease.
Topics: Adult; Aged; Aged, 80 and over; Double-Blind Method; Fatigue; Female; Follow-Up Studies; Humans; Indans; Male; Middle Aged; Neuroprotective Agents; Parkinson Disease; Pilot Projects; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome | 2015 |